Today the total direct medical and social care costs of Alzheimer’s disease in Europe amount to over €100 billion.
Alcheimera simptomus mēdz jaukt ar citām novecošanas pazīmēm, un liels ir tādu cilvēku skaits, kuri ar to slimo, nezinot.